Effects of alprazolam on increases in hormonal and anxiety levels induced by meta-chlorophenylpiperazine

Psychiatry Research

Volumn 53, Issue 3, 1994, Pages 219-229

  Sevy, Serge ^a   Brown, Serena Lynn ^a   Wetzler, Scott ^a   Kotler, Moshe ^a   Molcho, Avi ^a   Plutchik, Robert ^a   van Praag, Herman M ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

cortisol; growth hormone; prolactin; Serotonin

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; ALPRAZOLAM; GROWTH HORMONE; HYDROCORTISONE; PROLACTIN;

ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG THERAPY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PANIC; PRIORITY JOURNAL;

ADULT; ALPRAZOLAM; ANXIETY; AROUSAL; GROWTH HORMONE; HUMAN; HYDROCORTISONE; MALE; PANIC; PIPERAZINES; PREMEDICATION; PROLACTIN; SEROTONIN AGONISTS;

EID: 0028130456     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-1781(94)90051-5     Document Type: Article

References (45)

1. Anxiety disorders
2. Immunohistochemical evidence for the presence of gamma-aminobutyric acid and serotonin in one nerve cell. A study on the raphe nuclei of the rat using antibodies to glutamate decarboxylase and serotonin
3. Benzodiazepine receptor ligands with positive and negative efficacy
4. Intravenous diazepam fails to change growth hormone and cortisol secretion in humans
5. The inhibitory effect of GABA and melatonin on the release of corticotropin releasing hormone from the rat hypothalamus in vitro
6. Changes in plasma cortisol induced by dextroamphetamine and chlordiazepoxide given alone in combination in man
7. Behavioral, biochemical, and blood pressure responses to alprazolam in healthy subjects: Interactions with yohimbine
8. Benzodiazepine treatment of panic disorder: A comparison of alprazolam and lorazepam
9. Serotonin function in anxiety: II. Effects of the serotonin agoinst mCPP in panic disorder patients and healthy subjects
10. Alprazolam in the treatment of generalized anxiety and panic disorders: A double-blind placebo-controlled study
11. New concepts on the mechanism of action of benzodiazepines
12. Effect of bromazepam on growth hormone and prolactin secretion in normal subjects
13. Alprazolam: A review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression
14. A diagnostic interview: The Schedule for Affective Disorders and Schizophrenia
15. Evidence for a tonic GABAergic control of serotonin neurons in the median raphe nucleus
16. Benzodiazepine suppression of cortisol secretion: A measure of anxiolytic activity?
17. Electron captured gas chromatographic analysis of the triazolobenzodiazepine alprazolam and triazolam
18. Possible involvement of GABA in the central actions of benzodiazepines
19. Benzodiazepine sensitivity in normal human subjects
20. Neuroendocrine markers of CNS drug effects
21. Neuroendocrine evidence for serotonin receptor supersensitivity in patients with panic disorder
22. The effect of 5HT antagonists on m-chlorophenylpiperazine-mediated responses
23. m-Chlorophenylpiperazine as a probe of serotonin function
24. Pituitary hormone responses to m-chlorophenylpiperazine in patients with panic disorder and healthy subjects
25. The effects of m-chlorophenylpiperazine in normal subjects: A dose response study
26. In vitro and in vivo effects of the triazolobenzodiazepine alprazolam on hypothalamic-pituitary-adrenal function: Pharmacological and clinical implications
27. Behavioral hypersensitivity to m-chlorophenylpiperazine in a subject with subclinical panic attacks
28. A dose-response study of intravenous m-chlorophenylpiperazine in normal subjects
29. Effects of psychotropic drugs (desipramine, chlorimipramine, sulpride and diazepam) on the human HPA axis
30. Effects of GABA and GABA antagonist drugs on ACTH release
31. Alterations to plasma melatonin and cortisol after evening alprazolam administration in humans
32. Further studies of the putative serotonin agonist, m-chlorophenylpiperazine: Evidence for a serotonin receptor mediated mechanism of action in humans
33. Neuroendocrine effects of m-chlorophenylpiperazine, a serotonin agonist, in humans
34. Comparative anxiogenic, neuroendocrine, and other physiologic effects of m-chlorophenylpiperazine given intravenously and orally to healthy volunt eers
35. Involvement of the habenulo-raphe pathways in the GABAergic inhibition of ascending serotonergic neurons
36. Inhibitory influence of GABA on central serotonergic transmission: Raphe nuclei as the neuroanatomical site of the GABAergic inhibition of cerebral serotonergic neurons
37. Intravenous alprazolam challenge in normal subjects. Biochemical, cardiovascular, and behavioral effects
38. Effects of ritanserin on the behavioral, neuroendocrine, and cardiovascular responses to meta-chlorophenylpiperazine in healthy human subjects
39. Alprazolam blocks the naloxone-stimulated hypothalamo-pituitary-adrenal axis in man
40. Caffeine model of panic: Biological implications
41. Therapeutic indications for serotonin-potentiating compounds: A hypothesis
42. Situational panic attacks
43. Lack of effect of i.m. diazepam administration on HGH and HPRL secretion in normal and acromegalic subjects
44. Neuroendocrine and monoaminergic responses to acute administration of alprazolam in normal subjects